76 related articles for article (PubMed ID: 11791386)
1. [An elderly woman with breast cancer and multiple liver metastasis that responded well to combination therapy of fadrozole and tamoxifen].
Nakajima Y; Hirayama K; Saitoh K; Terashima H; Shimada T; Nishiyama S; Shimizu T
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2065-8. PubMed ID: 11791386
[TBL] [Abstract][Full Text] [Related]
2. [A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
Tominaga T; Kimura M; Toge T; Takashima S; Nomura Y; Ohashi Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1709-18. PubMed ID: 11057322
[TBL] [Abstract][Full Text] [Related]
3. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
Rai Y; Emi Y; Nishijima N; Kai S; Kano T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
[TBL] [Abstract][Full Text] [Related]
4. [Liver metastases from breast cancer 14 years after radical mastectomy; successful treatment with hepatic arterial infusion chemotherapy and systemic endocrine therapy--a case report].
Onogawa S; Ito K; Nishimura K; Umeda Y; Kojima K; Imai R; Nakajima N; Nakagami K; Tohyama K; Suzuki M; Arai K; Muro H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1804-8. PubMed ID: 9382537
[TBL] [Abstract][Full Text] [Related]
5. [A case of locally advanced breast cancer treated with hyperthermia in combination with radiotherapy].
Yamasaki M; Yayoi E; Kishibuchi M; Nishi T; Yagyu T; Kawasaki K; Ostapenko V; Nishide T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1746-8. PubMed ID: 11708024
[TBL] [Abstract][Full Text] [Related]
6. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide].
Rischke HC; Staib-Sebler E; Mose S; Adams SW; Herrmann G; Böttcher HD; Lorenz M
Dtsch Med Wochenschr; 1999 Feb; 124(7):182-6. PubMed ID: 10093577
[TBL] [Abstract][Full Text] [Related]
9. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of breast cancer markedly responded to neoadjuvant chemoendocrine therapy (2 cycles of CMF and tamoxifen, pCR and near pCR)].
Rai Y; Sagara Y; Sagara Y; Ooi Y
Gan To Kagaku Ryoho; 2004 Mar; 31(3):443-7. PubMed ID: 15045959
[TBL] [Abstract][Full Text] [Related]
11. [A case of giant advanced breast cancer responding remarkably to CEFT therapy].
Yano M; Kume K; Ono E; Wakasugi K; Matsuzaka T; Fujinaga H
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1067-70. PubMed ID: 8512336
[TBL] [Abstract][Full Text] [Related]
12. [Clinical trial of fadrozole hydrochloride for postmenopausal patients with recurrent breast cancer].
Kanzaki M; Nakaya Y; Kojima K; Toda H; Tobayama S; Machida H; Ohba M
Gan To Kagaku Ryoho; 1999 Jun; 26(7):959-65. PubMed ID: 10396324
[TBL] [Abstract][Full Text] [Related]
13. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
[TBL] [Abstract][Full Text] [Related]
14. Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
Dowsett M; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G; Smith IE
J Clin Oncol; 2005 Apr; 23(11):2477-92. PubMed ID: 15767642
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
Zaucha R; Sosińska-Mielcarek K; Jassem J
Breast; 2004 Aug; 13(4):321-4. PubMed ID: 15325667
[TBL] [Abstract][Full Text] [Related]
16. [A case of pleural and mediastinal lymph node metastases from breast cancer effectively treated with fadrozole hydrochloride in combination with cyclophosphamide].
Kokufu I; Kim YH; Peng YF; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
Gan To Kagaku Ryoho; 1999 Feb; 26(3):377-9. PubMed ID: 10065105
[TBL] [Abstract][Full Text] [Related]
17. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
18. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
20. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
